Md. Sabir Alam | Pharmaceutical sciences | Research Mentorship Award

Assoc Prof Dr. Md Sabir Alam | Pharmaceutical sciences | Research Mentorship Award

SGT College of Pharmacy, SGT University, India

Author Profile

Early Academic Pursuits 🎓

Dr. Md. Sabir Alam’s academic journey reflects a deep commitment to pharmaceutical sciences. His early interest in biopolymers and drug delivery systems laid a solid foundation for his future pursuits. Through rigorous training, he developed expertise in the synthesis and characterization of metallic nanoparticles, focusing on their potential applications in anticancer therapies, psoriasis treatments, and neurological disorders. His academic milestones have prepared him to contribute significantly to advanced pharmaceutical research.

Professional Endeavors 🏛️

With over 11 years of professional experience, Dr. Alam has consistently advanced the field of pharmaceutics. Since 24th December 2022, he has served as an Associate Professor at the SGT College of Pharmacy, SGT University, Gurgaon, where he imparts his extensive knowledge to the next generation of pharmaceutical scientists. His practical approach to teaching, coupled with real-world research insights, bridges the gap between academia and industry.

Research Focus 🔬

Dr. Alam’s research interests are rooted in innovative and sustainable methodologies:

  • Natural Biopolymer-Based Nanoparticles: Synthesizing nanoparticles using eco-friendly methods like microwave-mediated and hydrothermal synthesis, with a focus on gold, silver, and zinc nanoparticles for novel drug delivery systems.
  • Nanocarriers for Targeted Therapy: Investigating the role of hydroxyapatite nanoparticles in combating DNA damage and microbial infections.
  • Polymer Derivatives for Drug Delivery: Synthesizing novel derivatives of natural polymers for enhanced drug efficacy.
  • Animal Studies: Expertly handling albino mice and Wistar rats for testing psoriasis and epileptic treatments.

Contributions and Supervision 📚

Dr. Alam is actively involved in mentoring future researchers:

  • Supervising 3 Ph.D. scholars at prestigious universities, including Suresh Gyan Vihar University, K N Modi University, and OPJS University.
  • Acting as an external examiner for esteemed institutions such as Amity University, MVN University, and IIMT University for practical evaluations and project work.

Accolades and Recognition 🏆

Dr. Alam’s expertise and contributions have earned him notable accolades:

  • Ranked among the world’s top 10% scientists by the AD Scientific Index 2024, marking his excellence in research and academic impact for four consecutive editions.
  • Consistently appointed as a Paper Setter for advanced pharmaceutical subjects at universities such as Integral University, Lucknow, showcasing his mastery in pharmaceutics and pharmacokinetics.

Impact and Influence 🌟

Dr. Alam’s work has profoundly influenced pharmaceutical research and education. His development of biopolymer-based drug delivery systems promises breakthroughs in treating complex conditions like cancer and psoriasis. By integrating green synthesis techniques, he champions sustainability in scientific research. Furthermore, his role as a mentor has shaped numerous aspiring professionals, contributing to the growth of the pharmaceutical field.

Legacy and Future Contributions 🔮

Dr. Md. Sabir Alam’s legacy is marked by innovation, mentorship, and sustainability. His ongoing research on nanoparticles and drug delivery systems is poised to revolutionize healthcare. As he continues to collaborate with global institutions, his work will undoubtedly inspire future generations of scientists and researchers. His efforts to advance sustainable pharmaceutical practices and foster academic excellence will remain influential in shaping the future of drug delivery systems.

Conclusion 🌍

Dr. Alam’s remarkable journey from academia to professional excellence serves as a testament to his dedication and passion for pharmaceutical sciences. His impact extends beyond laboratories to classrooms, shaping a legacy of innovation, sustainability, and education.

Citations

A total of 846 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         846
  • h-index           40
  • i10-index        16

Notable Publications 

  • Title: An update on natural bioactive components of traditional preparations for the treatment of nephrolithiasis; a review
    Authors: Singh, P., Alam, M.S., Arif, M., Bhalla, V., Garg, A.
    Journal: Journal of Nephropharmacology
    Year: 2024.
  • Title: New Emerging Aspect of Herbal Extracts for the Treatment of Osteoporosis: Overview
    Authors: Kumari, P., Shirumalla, R.K., Bhalla, V., Alam, M.S.
    Journal: Current Rheumatology Reviews
    Year: 2024.
  • Title: Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
    Authors: Sethiya, N.K., Ghiloria, N., Srivastav, A., Walia, V., Alam, M.S.
    Journal: CNS and Neurological Disorders – Drug Targets
    Year: 2024.
  • Title: Pharmaceutical characterization and dissolution behavior of ibuprofen/Soluplus solvent cast films
    Authors: Salawi, A., Sonju, J.J., Nazzal, S., Kamal, M.M., Alam, M.S.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2023.
  • Title: Sustainable Nanotorus for Biosensing and Therapeutical Applications
    Authors: Naseh, M.F., Ansari, J.R., Alam, M.S., Javed, M.N.
    Journal: Handbook of Green and Sustainable Nanotechnology: Fundamentals, Developments and Applications: Volume 1-4
    Year: 2023.

Ananda Kumar Chettupalli | Pharmacy | Best Researcher Award

Dr. Ananda Kumar Chettupalli | Pharmacy | Best Researcher Award

Chettupalli Galgotias University, India

Author Profile

📚 Early Academic Pursuits

Dr. Chettupalli’s academic journey began with his foundational education in pharmacy. He obtained his Bachelor of Pharmacy degree in 2010 from Nirmala College of Pharmaceutical Sciences, affiliated with Acharya Nagarjuna University, where he gained a solid grounding in pharmaceutical principles and practices. During his undergraduate studies, Dr. Chettupalli demonstrated a keen interest in drug formulation and delivery systems, laying the groundwork for his future contributions to the field.Following his undergraduate studies, Dr. Chettupalli pursued his Master of Pharmacy (M.Pharm) in 2012 from A.M. Reddy College of Pharmacy, also affiliated with Acharya Nagarjuna University. Specializing in Pharmaceutics, he explored innovative methods of drug formulation. His M.Pharm thesis, titled “Development of Itraconazole Immediate Release Pellets by Using HPMC Loaded in Gelatin Capsules,” showcased his expertise in formulation science and his focus on enhancing drug solubility and bioavailability—challenges central to modern pharmacotherapy.

🧪 Research and Contributions

Dr. Chettupalli earned his Ph.D. in Pharmaceutical Sciences from Shri Jagdish Prasad Jhabarmal Tibrewala University in Rajasthan in 2016. His doctoral research, “Design and Characterization of Carvedilol Ethosomes as a Transdermal Drug Delivery System,” involved developing a transdermal delivery system for Carvedilol, a widely used cardiovascular drug. This innovative approach aimed to optimize therapeutic efficacy while minimizing side effects, emphasizing his focus on patient-centered pharmacology. His research marked an important step toward more effective and convenient treatment methods for chronic diseases through enhanced transdermal drug delivery systems.

🏆 Professional Endeavors and Experience

With a career spanning 12 years and 8 months, Dr. Chettupalli has gained extensive experience as an academic and researcher. Throughout his career, he has demonstrated a strong commitment to pharmaceutical education and research, bridging the gap between theory and practice. His experience in teaching has allowed him to mentor future pharmacists and pharmaceutical scientists, imparting both foundational knowledge and advanced skills in drug development and delivery systems.In addition to his role as an educator, Dr. Chettupalli has actively engaged in research focused on formulation science, nanotechnology, and transdermal systems, contributing to the ongoing evolution of pharmaceutical technology. His work on the development of immediate-release formulations and transdermal applications reflects his dedication to improving patient compliance and therapeutic outcomes through innovative drug delivery strategies.

🌍 Impact and Influence

Dr. Chettupalli’s research on transdermal drug delivery systems has contributed significantly to the advancement of non-invasive treatment modalities. By developing Carvedilol ethosomes for transdermal administration, he has provided a model for enhancing drug penetration through the skin barrier, potentially revolutionizing the treatment options available for patients with cardiovascular conditions. His contributions to formulation science have paved the way for more effective therapies with fewer adverse effects, which is particularly important in the management of chronic conditions.Moreover, Dr. Chettupalli’s influence extends beyond his immediate research, as his expertise in formulation and nanotechnology continues to inspire a new generation of pharmaceutical scientists. His commitment to bridging clinical relevance with academic rigor serves as a model for aspiring researchers in the field.

🏅 Accolades and Recognition

Over the years, Dr. Chettupalli has received recognition for his contributions to the field of pharmaceutics. His work has been appreciated by academic peers and students alike, who recognize his dedication to quality research and his skill in making complex topics accessible. While specific awards and honors may not be listed here, Dr. Chettupalli’s ongoing influence as an educator and researcher serves as a testament to his excellence in the field.

💡 Legacy and Future Contributions

Dr. Chettupalli’s impact on pharmaceutical sciences, particularly in the area of drug delivery systems, is likely to endure for years to come. As he continues his work in pharmaceutics, he is poised to make further contributions to transdermal drug delivery and nanotechnology applications. His research on ethosomes has the potential to inspire further studies on the transdermal delivery of other therapeutic agents, potentially offering new treatments for a range of conditions.Looking to the future, Dr. Chettupalli is expected to expand his research on innovative drug delivery mechanisms, possibly incorporating advanced nanotechnology and biodegradable polymers to develop environmentally sustainable and patient-friendly pharmaceuticals. His career reflects a dedication to both scientific advancement and patient welfare, and his work will likely continue to influence the fields of formulation science and clinical pharmacology.

🌟 Conclusion: A Lasting Contribution

Dr. Ananda Kumar Chettupalli’s career in pharmaceutical sciences exemplifies the power of combining academic knowledge with practical innovation. From his early studies in pharmacy to his specialized work in transdermal drug delivery, he has contributed significantly to the fields of pharmaceutics and drug formulation. His ongoing dedication to education and research underscores his commitment to improving healthcare and advancing the pharmaceutical sciences, and his work will continue to benefit both students and patients for years to come.

Citations

A total of 228 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         228
  • h-index           19
  • i10-index        09

Notable Publications 

  • “Improved Transdermal Delivery of Anti-hypertensive Drug Loaded Nanostructured Lipid Carriers: Statistical Design, Optimization, Depiction and Pharmacokinetic Assessment”
    • Authors: Chettupalli, A.K., Avula, P.R., Chauhan, V.
    • Journal: Current Drug Therapy, 2024.
  • “Design Formulation of Nanospanlastic Novel Carriers as a Promising Approach to Enhanced Bioavailability in Intranasal Drug Delivery for Sinusitis: Statistical Optimization and In vitro and In vivo Characterization”
    • Authors: Chettupalli, A.K., Ajmera, S., Kuchukuntla, M., Palanivel, V., Katta, S.
    • Journal: Current Nanomedicine, 2024.
  • “Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations”
    • Authors: Unnisa, A., Chettupalli, A.K., Alazragi, R.S., Mohamed, O.A., Hussain, T.
    • Journal: Pharmaceuticals, 2023.
  • “Quality by Design Approach for Preparation, Characterization, and Statistical Optimization of Naproxen Sodium-loaded Ethosomes via Transdermal Route”
    • Authors: Chettupalli, A.K., Ajmera, S., Amarachinta, P.R., Manda, R.M., Jadi, R.K.
    • Journal: Current Bioactive Compounds, 2023.
  • “In silico elucidation of plausible anti-obesity activity by Withaferin-A compound targeting alpha-amylase”
    • Authors: Alafnan, A., Chettupalli, A.K., Unnisa, A., Anupama, B., Lakshmi, K.N.V.C.
    • Journal: European Review for Medical and Pharmacological Sciences, 2023.

Archana Kapoor | Pharmaceutical | Best Researcher Award

Prof. Archana Kapoor | Pharmaceutical | Best Researcher Award

Guru Jambheshwar University of Science & Technology-India

Author Profile

Early Academic Pursuits 📚

Born on October 25, 1978, Archana Kapoor embarked on her academic journey with a passion for pharmaceutical sciences. She pursued her undergraduate and postgraduate studies in Pharmaceutical Chemistry at Punjab University, Chandigarh, one of India’s premier institutions. Earning her post-graduation in 2003, she honed her expertise in drug discovery, medicinal chemistry, and pharmacokinetics. Her strong foundation in chemistry and pharmaceutical sciences earned her a GATE scholarship, a prestigious recognition of her academic excellence. Archana further enhanced her academic credentials by completing her Doctorate in Pharmaceutical Sciences from Guru Jambheshwar University of Science & Technology in 2016, marking a significant milestone in her pursuit of scientific knowledge and innovation.

Professional Endeavors 👩‍🔬

With almost 18 years of experience, Archana Kapoor’s career reflects her dedication to bridging the gap between academic research and industrial application. She commenced her professional journey in 2006 by joining Dr. Reddy’s Laboratories, Hyderabad, as a Scientist in the Discovery Chemistry section. During her tenure at Dr. Reddy’s, she gained invaluable experience in drug metabolism, pharmacokinetics, and advanced bioanalytical techniques such as HPLC and LC-MS/MS. Her work in the AMPK kinase project focused on developing lead series for Type-II Diabetes, contributing to the global efforts in combating this widespread condition.In 2016, Archana transitioned into academia, where she now serves as a Professor in the Department of Pharmaceutical Sciences at Guru Jambheshwar University of Science & Technology. Here, she plays a pivotal role in teaching, mentoring students, and spearheading research initiatives. Her ability to integrate real-world experience with academic learning has made her a respected figure among her peers and students alike.

Contributions and Research Focus 🔬

Archana Kapoor’s research portfolio is a testament to her deep commitment to advancing pharmaceutical sciences. Her work spans drug discovery, molecular docking, and pharmacokinetic analysis. One of her most significant contributions is her research on “5-Nitro-N-phenyl-3-(phenylamino)-1H-indazole-1-carboxamide Derivatives as Potential Anticancer Agents.” This study integrates chemical synthesis, in silico docking, and molecular dynamics simulations to explore new anticancer agents. The innovation in this research lies in its multi-faceted approach, targeting not just the synthesis of compounds but also analyzing their molecular interactions to optimize their efficacy as anticancer drugs.Her contributions to the discovery and development of new therapeutic agents extend beyond cancer treatment. While working at Dr. Reddy’s, Archana played a crucial role in the R&D sector, contributing to key projects that focused on metabolic disorders like Type-II Diabetes. Her experience with leading pharmaceutical companies and her academic background allows her to bring a comprehensive perspective to the challenges in drug discovery.

Innovations in Pharmaceutical Sciences 💡

Archana has consistently leveraged cutting-edge technology in her research, particularly in the integration of computational methods with experimental data. Her use of in silico techniques for drug discovery, including molecular docking and simulations, has streamlined the identification of promising drug candidates, saving both time and resources. By combining computational approaches with traditional experimental methods, Archana’s research has opened new avenues for discovering efficient and targeted therapeutic solutions.Her innovative methodologies reflect her forward-thinking approach and her drive to push the boundaries of pharmaceutical research. This integration of technology into drug discovery processes ensures that her work not only meets current scientific standards but also sets the stage for future advancements in the field.

Accolades and Recognition 🏆

Throughout her career, Archana Kapoor has been recognized for her exceptional contributions to pharmaceutical sciences. She has been the recipient of several awards and honors, including a prestigious Award of Honour for her exemplary efforts in education and research. Her research publications in renowned scientific journals and her presentations at international conferences have further solidified her standing as a leader in her field.Her work has also earned her recognition within the scientific community for her research on novel anticancer agents. The synthesis and analysis of new chemical compounds that can potentially contribute to cancer treatment has positioned her as an influential voice in pharmaceutical research. Additionally, her GATE scholarship during her postgraduate studies underscores her academic brilliance and commitment to excellence.

Impact and Influence 🌍

Archana Kapoor’s impact extends beyond her own research; she has become a mentor and a guide for the next generation of pharmaceutical scientists. As a professor, she has not only imparted knowledge but has also encouraged her students to engage in innovative thinking and research. Her leadership in various academic and research initiatives at Guru Jambheshwar University has led to the establishment of strong research networks and collaborations, fostering a culture of inquiry and innovation.Her participation in seminars, workshops, and conferences has further contributed to knowledge dissemination and professional networking. She has been instrumental in organizing academic events that bring together experts from various fields to discuss advancements in pharmaceutical sciences. Through these efforts, Archana has become a key figure in the pharmaceutical academic community, influencing both her peers and her students.

Legacy and Future Contributions 🌱

Looking ahead, Archana Kapoor is committed to continuing her research in drug discovery, with a specific focus on developing new therapeutic agents for cancer and metabolic diseases. Her interdisciplinary approach, combining chemistry, pharmacology, and computational methods, promises to drive future innovations in pharmaceutical research.In addition to her research contributions, Archana aims to continue her mentorship role, guiding young scientists and researchers in their academic and professional journeys. Her legacy is not only defined by her own research achievements but also by the impact she has had on shaping the future of pharmaceutical sciences through her students.

Citations

A total of 208 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         208
  • h-index           8
  • i10-index        6

Notable Publications 

  • Exploration of N‐(6‐Indazolyl) Benzenesulfonamide Derivatives as Potential Antioxidants and Antimicrobial Agents: Integrating Synthesis, In Silico Docking, and Bioactivity
    Authors: M. Yadav, R. Rao, S. Kumar, A. Kapoor
    Journal: ChemistrySelect, Vol. 8 (45), 2023
  • Development of 2-Dimensional and 3-Dimensional QSAR Models of Indazole Derivatives as TTK Inhibitors Having Anticancer Potential
    Authors: A.K. Mithlesh Yadav, Balasubramanian Narasimhan
    Journal: Current Chemistry Letters, Vol. 13 (1), 2023
  • Hybrid Descriptors–Conjoint Indices: A Case Study on Imidazole-Thiourea Containing Glutaminyl Cyclase Inhibitors for Design of Novel Anti-Alzheimer’s Candidates
    Authors: K. Bagri, A. Kapoor, P. Kumar, A. Kumar
    Journal: SAR and QSAR in Environmental Research, Vol. 34 (5), 2023
  • Anti-Hyperglycemic Evaluation of 2,4-Thiazolidinedione and Rhodanine Derivatives
    Authors: A. Kapoor, N. Khare
    Journal: Der Pharma Chemica, Vol. 8 (12), 2016
  • A Review on the Drug Delivery Strategies for Parasitic Infections: Scope and Assertion
    Authors: M. Bhatia, S. Kumar, A. Kapoor, S. Lohan
    Journal: Drug Delivery Letters, Vol. 12 (2), 2022.